jermaine posted - "and why I am still very skeptical about RVX is; why has no reputable North American or European Pharma come forth."

We do know a couple of things about the large, reputable BP's.

• RVX's sister company Zenith is involved with a number of reputable BPs and the NIC with zen3694.
• In one of Don's presentations when he talked about BoM2 a BP proposed a 5 year trial which RVX turned down because it was too long.

So we know there is some interaction. I started buying RVX after the "brown envelop" tall tale and since then I know very little about RVX's interations with BPs. I have wondered about this as well. We have a couple of failed trials which I assumed failed because of insufficient statistical power. However, the trial designs included biostatisticians in the development of the research. The follow up research has been very enlightening and powerful, I think, in the T2D CKD patients. Are BP's at the door but with small purses as has been conjectured? What do BP's think of the BETi science and specifically apabetalone? We or at least I have not got a clue. Surely they(BPs) attend the scientific conferences and study prestigious journals. Is the thinking something like "we're intriqued but give us real proof?".

One thing I feel strongly about is that if this quirky approach to financing actually works and if the Covid trial(s) is a success and apabetalone goes to market sccessfully in any country then BP will be paying a very large price for RVX and possibly Zenith. If profitable revenue is generated and begins to flow through to ZCC, then, ZCC's value should sky rocket. If the Covid trial fails I believe that both RVX and Zenith will carry on to develop the science. I'll just sit back for another 5 years and wait. By that time Don will be close to 70. What will ORI Capital be doing to generate their ROI. The possibilites are numerous for sure.

For now I can hardly wait until we move into the stage in which the medical and science posters like bdaz are all excited again and providing lots of fun science information to us laypeople.

It sure would be great to pick Ken Lebioda's brain (hope I got the right guy). He could clear everything up quickly but I'm sure he is bound by confidentially.

Mushroom management is alive and thriving at RVX.

GLTA

Toinv